Literature DB >> 3041655

Use of the caprinised strain of rinderpest virus for potency testing an attenuated cell culture rinderpest vaccine.

F Guillemin1, P Jouvenet, M Mosienyane, M Mannathoko.   

Abstract

The caprinised strain of rinderpest virus was inoculated into goats to produce a challenge stock. These goats were kept with control animals (goats, sheep, calves). In this trial the caprinised strain was shown to have a mild pathogenicity for goats and it spread to one of two contact goats but not from goats to other species. The caprinised strain was then tested on cattle where a febrile reaction was observed. The caprinised strain also did not spread between cattle. The cattle vaccinated with a freeze-dried vaccine produced from the attenuated Kabete RBKO strain on bovine kidney cells were then challenged with the caprinised strain with good results.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3041655     DOI: 10.1007/BF02242236

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  1 in total

1.  Freeze-dried vaccine against Rinderpest: stability and activity study.

Authors:  B Languet; P Precausta; M Mackowiak; P Dubourget; G Reynaud; C Duret
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1985       Impact factor: 2.268

  1 in total
  1 in total

1.  Assessment of the control measures of category A diseases of the Animal Health Law: Infection with rinderpest virus (Rinderpest).

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Simon Gubbins; Genevieve Libeau; Andrea Gervelmeyer; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.